<code id='62FAA2AD21'></code><style id='62FAA2AD21'></style>
    • <acronym id='62FAA2AD21'></acronym>
      <center id='62FAA2AD21'><center id='62FAA2AD21'><tfoot id='62FAA2AD21'></tfoot></center><abbr id='62FAA2AD21'><dir id='62FAA2AD21'><tfoot id='62FAA2AD21'></tfoot><noframes id='62FAA2AD21'>

    • <optgroup id='62FAA2AD21'><strike id='62FAA2AD21'><sup id='62FAA2AD21'></sup></strike><code id='62FAA2AD21'></code></optgroup>
        1. <b id='62FAA2AD21'><label id='62FAA2AD21'><select id='62FAA2AD21'><dt id='62FAA2AD21'><span id='62FAA2AD21'></span></dt></select></label></b><u id='62FAA2AD21'></u>
          <i id='62FAA2AD21'><strike id='62FAA2AD21'><tt id='62FAA2AD21'><pre id='62FAA2AD21'></pre></tt></strike></i>

          fashion

          fashion

          author:comprehensive    Page View:52
          Frank Pallone -- health policy coverage from STAT
          Rep. Frank Pallone (D-N.J.) J. Scott Applewhite/AP

          WASHINGTON — A Democrat has signed on to a legislative package that would require health care transparency by law and enact modest payment reforms to pharmacy middlemen and hospitals, increasing its chances of passing the House of Representatives.

          Republicans conceded to a few tweaks to the legislation to ensure that transparency regulations for hospitals were at least equal to current regulations, which gained the endorsement of House Energy and Commerce Committee ranking member Frank Pallone (D-N.J.).

          advertisement

          Two other prominent Democrats on relevant committees didn’t sign on: Rep. Richard Neal (D-Mass.), who had voiced concerns about the bill’s lack of transparency provisions requiring disclosure of private equity ownership, and Rep. Bobby Scott (D-Va.).

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          leisure time

          Drug repurposing or repositioning? The language matters
          Drug repurposing or repositioning? The language matters

          AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

          read more
          WuXi out of biotech trade group, U.S. and China relations to blame
          WuXi out of biotech trade group, U.S. and China relations to blame

          AdobeWASHINGTON—TheBiotechnologyInnovationOrganization,anindustrytradegroup,iscuttingtieswithChinese

          read more
          Dobbs anniversary: the lost opportunity of abortion as health care
          Dobbs anniversary: the lost opportunity of abortion as health care

          NathanHoward/GettyImagesReflectingonthisfirstanniversaryoftheSupremeCourt’sdecisioninDobbstooverturn

          read more

          Acadia's Nuplazid fails as schizophrenia medicine in Phase 3 study

          AdobeAcadiaPharmaceuticalssaidMondaythatitsapprovedmedicinecalledNuplazidfailedtoimprovethesocialand